LOVELAND, Colo., Oct. 9, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today that it has filed with the Securities and Exchange Commission (“SEC”) an amendment to its offer to purchase. As described in its offer to purchase, the Company is offering $9.50 for each share of its common stock held by stockholders who owned, of record or beneficially, 99 or fewer shares as of the close of business on August 21, 2012, and who continue to hold such shares through the expiration of the offer.
Investors may obtain copies of the Company’s Schedule TO filed August 27, 2012, the amendment filed on September 14, 2012, the amendment filed on Schedule 13E-3 on September 25, 2012, and the amendment filed today from the SEC at no charge by visiting the SEC’s website (www.sec.gov). With today’s amendment, the Company filed an Amended Offer to Purchase, Amended Letter of Transmittal, and Amended Notice of Guaranteed Delivery, which reflect all amendments made to date. The Company will make copies available to interested stockholders upon request. Company stockholders with questions or requests for documents, including a copy of the Amended Offer to Purchase, Amended Letter of Transmittal, and Amended Notice of Guaranteed Delivery, may call the Company’s information agent in this matter, Morrow & Co., LLC, at (800) 607-0088.
The following details the changes made to the offer to purchase. Except as otherwise noted below, no changes have been made to the Schedule 13E-3 filed by the Company on September 25, 2012. |
